Evaluation of methods to identify chemotherapy‐related hematologic toxicities in real‐world settings

Hematologic toxicities are common in those receiving chemotherapy and can affect subsequent treatment delivery and patient outcomes. Laboratory results and International Classification of Diseases (ICD) codes are often used to define toxicities in real-world settings; optimal use of this information for research remains unclear. In 854 women receiving adjuvant chemotherapy for stage I-IIIA breast cancer with abstracted medical record data at Kaiser Permanente Washington, we defined three chemotherapy-related hematologic toxicities (anemia, neutropenia, and thrombocytopenia) using laboratory data, ICD codes, and a combination of both during and up to 1 month after chemotherapy. Cutpoints for laboratory values corresponding to grades 1-3 were derived from Common Terminology Criteria for Adverse Events. We examined sensitivity, specificity, and positive predictive value (PPV), comparing laboratory and ICD definitions to chart review. Chart review identified 180 women with anemia, 168 with neutropenia, and 21 with thrombocytopenia. Grade-1+ showed the highest sensitivity for all toxicities (range: 0.84-0.95) but lowest specificity (range: 0.45-0.86) and PPV (range: 0.14-0.47). Grade-3+ showed the lowest sensitivity for all toxicities (range: 0.13-0.59) and highest specificity (range: 0.85-1.00) and PPV (range: 0.63-0.82). ICD and grade-2+ each showed balanced performance across toxicities, with ICD having slightly higher sensitivity (range: 0.62-0.76) than grade-2+ (range: 0.48-0.77). Combining grade-2+ and ICD improved sensitivity (range: 0.76-0.93) for all toxicities without much loss of specificity (range: 0.64-0.98), and no change to PPV. In conclusion, ICD and grade-2+ showed moderate-to-good performance for defining hematologic toxicities; the combination of laboratory data (especially grade-2+) and ICD showed better performance than either source alone.

Authors

Institutions

Publication Details

Journal
International Journal of Cancer
Published
2025-11-28
DOI
https://doi.org/10.1002/ijc.70266
Primary Topic
Neutropenia and Cancer Infections
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of methods to identify chemotherapy‐related hematologic toxicities in real‐world settings

Elisa V. Bandera, Emily Valice, Jenna Bhimani, Kanichi G. Nakata et al.
International Journal of Cancer
Neutropenia and Cancer Infections
article

Evaluation of methods to identify chemotherapy‐related hematologic toxicities in real‐world settings

Elisa V. Bandera, Emily Valice, Jenna Bhimani, Kanichi G. Nakata, Maria J. Monroy‐Iglesias, Isaac Joshua Ergas, Tatjana Kolevska, Kelli O’Connell, Raymond Liu, Lawrence H. Kushi, Rachael Burganowski, Sara Tabatabai, Erin J. Aiello Bowles, Sonia Persaud, Yuriy Kotsurovskyy, Grace B Gallagher, Janise M. Roh, Narre Heon, Candyce H. Kroenke, Jennifer J. Griggs, Elizabeth D. Kantor, Victoria Blinder, Cecile A. Laurent, Peng Wang, Yashasvini Sampathkumar
article en

Abstract

Hematologic toxicities are common in those receiving chemotherapy and can affect subsequent treatment delivery and patient outcomes. Laboratory results and International Classification of Diseases (ICD) codes are often used to define toxicities in real-world settings; optimal use of this information for research remains unclear. In 854 women receiving adjuvant chemotherapy for stage I-IIIA breast cancer with abstracted medical record data at Kaiser Permanente Washington, we defined three chemotherapy-related hematologic toxicities (anemia, neutropenia, and thrombocytopenia) using laboratory data, ICD codes, and a combination of both during and up to 1 month after chemotherapy. Cutpoints for laboratory values corresponding to grades 1-3 were derived from Common Terminology Criteria for Adverse Events. We examined sensitivity, specificity, and positive predictive value (PPV), comparing laboratory and ICD definitions to chart review. Chart review identified 180 women with anemia, 168 with neutropenia, and 21 with thrombocytopenia. Grade-1+ showed the highest sensitivity for all toxicities (range: 0.84-0.95) but lowest specificity (range: 0.45-0.86) and PPV (range: 0.14-0.47). Grade-3+ showed the lowest sensitivity for all toxicities (range: 0.13-0.59) and highest specificity (range: 0.85-1.00) and PPV (range: 0.63-0.82). ICD and grade-2+ each showed balanced performance across toxicities, with ICD having slightly higher sensitivity (range: 0.62-0.76) than grade-2+ (range: 0.48-0.77). Combining grade-2+ and ICD improved sensitivity (range: 0.76-0.93) for all toxicities without much loss of specificity (range: 0.64-0.98), and no change to PPV. In conclusion, ICD and grade-2+ showed moderate-to-good performance for defining hematologic toxicities; the combination of laboratory data (especially grade-2+) and ICD showed better performance than either source alone.

International Journal of CancerVol. 158(6)
Rutgers, The State University of New Jersey (US), Memorial Sloan Kettering Cancer Center (US), Kaiser Permanente (US), Kaiser Permanente Washington Health Research Institute (US), Cornell University (US), University of Michigan (US), Michigan Medicine (US), Kaiser Permanente Vallejo Medical Center (US), Kaiser Permanente San Francisco Medical Center (US), Weill Cornell Medicine (US)
Openalex Percentile: Top 48%
Neutropenia and Cancer Infections
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.